A new GTF2I-BRAF fusion mediating MAPK pathway activation in pilocytic astrocytoma
暂无分享,去创建一个
Birgitta Lannering | P. Åman | M. Tisell | B. Lannering | M. Sabel | F. Enlund | H. Sjögren | Tommy Martinsson | S. Dósa | T. Martinsson | F. Abel | Tajana Tešan Tomić | Josefin Olausson | Annica Wilzén | Magnus Sabel | Katarina Truvé | Helene Sjögren | Sándor Dósa | Magnus Tisell | Fredrik Enlund | Pierre Åman | Frida Abel | K. Truvé | Josefin Olausson | Annica Wilzén | T. Tomić | Katarina Truvé
[1] A. Montpetit,et al. Duplication of 7q34 is specific to juvenile pilocytic astrocytomas and a hallmark of cerebellar and optic pathway tumours , 2009, British Journal of Cancer.
[2] Jing Ma,et al. Activation of the ERK/MAPK pathway: a signature genetic defect in posterior fossa pilocytic astrocytomas , 2009, The Journal of pathology.
[3] P. Sharp,et al. Opposing functions of TFII-I spliced isoforms in growth factor-induced gene expression. , 2006, Molecular cell.
[4] C. Peyssonnaux,et al. The Raf/MEK/ERK pathway: new concepts of activation , 2001, Biology of the cell.
[5] T. Jacques,et al. RAF gene fusions are specific to pilocytic astrocytoma in a broad paediatric brain tumour cohort , 2010, Acta Neuropathologica.
[6] D. Gutmann,et al. Novel BRAF Alteration in a Sporadic Pilocytic Astrocytoma , 2012, Case reports in medicine.
[7] L. Cannon-Albright,et al. Co-prevalence of other tumors in patients harboring pituitary tumors. , 2014, Journal of neurosurgery.
[8] Ian F. Pollack,et al. Pathologist Interobserver Variability of Histologic Features in Childhood Brain Tumors: Results from the CCG-945 Study , 2008, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.
[9] David T. W. Jones,et al. Phase II study of sorafenib in children with recurrent or progressive low-grade astrocytomas. , 2014, Neuro-oncology.
[10] Kai Wang,et al. The distribution of BRAF gene fusions in solid tumors and response to targeted therapy , 2015, International journal of cancer.
[11] T. Shaikh,et al. Duplication of 7q34 in Pediatric Low‐Grade Astrocytomas Detected by High‐Density Single‐Nucleotide Polymorphism‐Based Genotype Arrays Results in a Novel BRAF Fusion Gene , 2009, Brain pathology.
[12] M. Barbieri,et al. The role of endocytic Rab GTPases in regulation of growth factor signaling and the migration and invasion of tumor cells , 2015, Small GTPases.
[13] W. J. Kent,et al. BLAT--the BLAST-like alignment tool. , 2002, Genome research.
[14] D. Louis. WHO classification of tumours of the central nervous system , 2007 .
[15] B. Scheithauer,et al. The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.
[16] A. Nicholson,et al. Mutations of the BRAF gene in human cancer , 2002, Nature.
[17] A. Hegde,et al. Coexisting intracranial tumors with pituitary adenomas: genetic association or coincidence? , 2010, Journal of cancer research and therapeutics.
[18] D. Pearson,et al. Oncogenic RAF1 rearrangement and a novel BRAF mutation as alternatives to KIAA1549:BRAF fusion in activating the MAPK pathway in pilocytic astrocytoma , 2009, Oncogene.
[19] L. Garraway,et al. Detection of KIAA1549-BRAF fusion transcripts in formalin-fixed paraffin-embedded pediatric low-grade gliomas. , 2011, The Journal of molecular diagnostics : JMD.
[20] D. Gutmann,et al. Pediatric glioma-associated KIAA1549:BRAF expression regulates neuroglial cell growth in a cell type-specific and mTOR-dependent manner. , 2012, Genes & development.
[21] G. Gustafsson,et al. Classification, incidence and survival analyses of children with CNS tumours diagnosed in Sweden 1984–2005 , 2009, Acta paediatrica.
[22] David T. W. Jones,et al. Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas. , 2008, Cancer research.
[23] Qingguo Wang,et al. Application of next generation sequencing to human gene fusion detection: computational tools, features and perspectives , 2013, Briefings Bioinform..
[24] Fausto J. Rodriguez,et al. BRAF Alterations in Primary Glial and Glioneuronal Neoplasms of the Central Nervous System With Identification of 2 Novel KIAA1549: BRAF Fusion Variants , 2012, Journal of neuropathology and experimental neurology.
[25] T. Merchant,et al. Survival and long-term health and cognitive outcomes after low-grade glioma. , 2011, Neuro-oncology.
[26] A. Roy. Biochemistry and biology of the inducible multifunctional transcription factor TFII-I: 10 years later. , 2012, Gene.
[27] A. Resnick,et al. Paradoxical activation and RAF inhibitor resistance of BRAF protein kinase fusions characterizing pediatric astrocytomas , 2013, Proceedings of the National Academy of Sciences.
[28] Jill S. Barnholtz-Sloan,et al. Childhood Brain Tumor Epidemiology: A Brain Tumor Epidemiology Consortium Review , 2014, Cancer Epidemiology, Biomarkers & Prevention.
[29] Marco Beccuti,et al. State of art fusion-finder algorithms are suitable to detect transcription-induced chimeras in normal tissues? , 2013, BMC Bioinformatics.
[30] Thomas Lengauer,et al. BMC Bioinformatics Methodology article Local protein structure prediction using discriminative models , 2006 .
[31] F. Mertens,et al. A novel GTF2I/NCOA2 fusion gene emphasizes the role of NCOA2 in soft tissue angiofibroma development , 2013, Genes, chromosomes & cancer.
[32] Adrian V. Lee,et al. Comprehensive evaluation of fusion transcript detection algorithms and a meta-caller to combine top performing methods in paired-end RNA-seq data , 2015, Nucleic acids research.
[33] O. Kallioniemi,et al. FusionCatcher – a tool for finding somatic fusion genes in paired-end RNA-sequencing data , 2014, bioRxiv.
[34] K. Kurian,et al. Current Understanding of BRAF Alterations in Diagnosis, Prognosis, and Therapeutic Targeting in Pediatric Low-Grade Gliomas , 2015, Front. Oncol..
[35] Y. Yonekawa,et al. A population-based study of the incidence and survival rates in patients with pilocytic astrocytoma. , 2003, Journal of neurosurgery.
[36] David T. W. Jones,et al. MAPK pathway activation in pilocytic astrocytoma , 2011, Cellular and Molecular Life Sciences.
[37] J. Biegel,et al. Chromosome Band 7q34 Deletions Resulting in KIAA1549‐BRAF and FAM131B‐BRAF Fusions in Pediatric Low‐Grade Gliomas , 2015, Brain pathology.
[38] S. Holmen,et al. The BRAF kinase domain promotes the development of gliomas in vivo , 2015, Genes & cancer.
[39] M. Varella‐Garcia,et al. KIAA1549: BRAF Gene Fusion and FGFR1 Hotspot Mutations Are Prognostic Factors in Pilocytic Astrocytomas , 2015, Journal of neuropathology and experimental neurology.
[40] Guang-Biao Zhou,et al. GTF2I‐RARA is a novel fusion transcript in a t(7;17) variant of acute promyelocytic leukaemia with clinical resistance to retinoic acid , 2015, British journal of haematology.
[41] Kirsten Schmieder,et al. Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma , 2011, Acta Neuropathologica.
[42] Roland Eils,et al. Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma , 2013, Nature Genetics.
[43] Chao Zhang,et al. RAF inhibitors transactivate RAF dimers and ERK signaling in cells with wild-type BRAF , 2010, Nature.
[44] David T. W. Jones,et al. Oncogenic FAM131B–BRAF fusion resulting from 7q34 deletion comprises an alternative mechanism of MAPK pathway activation in pilocytic astrocytoma , 2011, Acta Neuropathologica.